![](/img/cover-not-exists.png)
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts
Póti, Ádám, Berta, Kinga, Xiao, Yonghong, Pipek, Orsolya, Klus, Gregory T., Ried, Thomas, Csabai, István, Wilcoxen, Keith, Mikule, Keith, Szallasi, Zoltan, Szüts, DávidLanguage:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0312-6
Date:
November, 2018
File:
PDF, 777 KB
english, 2018